Life Sciences Consonance - Dec 1, 2020 Form 4/A - Amendment Insider Report for Consonance-HFW Acquisition Corp. (SRZN)

Role: Director, 10%+ Owner
Signature: /s/ Kevin Livingston, Manager of Consonance Life Sciences, LLC
Stock symbol: SRZN
Transactions as of: Dec 1, 2020
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 5/19/2021, 06:27 PM
Date Of Original Report: Dec 3, 2020
Previous filing: May 19, 2021
Next filing: Aug 13, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SRZN	Class A Ordinary Shares	Award		+24K	+5.85%		434K	Dec 1, 2020	Direct	F1, F2, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SRZN	Warrant	Award		+8K	+5.85%		145K	Dec 1, 2020	Class A Ordinary Shares	8K	$11.50	Direct	F1, F2, F3, F4, F5, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes securities underlying the 24,000 private placement units of the Issuer purchased by Consonance Life Sciences, LLC (the "Sponsor") for $10.00 per private placement unit. The private placement units were purchased in a private placement upon the exercise in full of the over-allotment option granted to the underwriters to purchase additional shares in the Issuer's initial public offering. Each unit consists of one share of Class A ordinary share and one-third of one warrant, with each whole warrant entitling the holder to purchase one share of Class A ordinary share at $11.50 per share.
F2	The Reporting Person is the record holder of the shares and warrants reported herein. The Reporting Person is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston have voting and investment discretion of the shares held by the Reporting Person and may be deemed to have shared beneficial ownership of the shares held by the Reporting Person. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly.
F3	The warrants will become exercisable on the later of (a) 30 days after the completion of the Issuer's initial business combination or (b) 12 months from the closing of the Issuer's initial public offering.
F4	The warrants will expire five years after the completion of the Issuer's initial business combination.
F5	Includes 8,000 warrants underlying the units referred to in footnote 1.
F6	This Form 4 amendment is being filed to correct the original Form 4 filed on December 3, 2020. The original Form 4 had the incorrect transaction code.